Fine Tuning: Stanching the British Brain Drain

One-quarter of the 200-plus UK science organizations surveyed in a recent Science Recruitment Group (SRG) study agreed that a skills shortage affects most science disciplines. UK researchers have been leaving the country for better-paid climes abroad for a number of years, although the events of Sep. 11 may prompt some to reconsider their plans. The lure of greater monetary rewards and better information technology has also resulted in the loss of science graduates. In the SRG survey, pharmaceu

Written byEmma Mills
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the SRG survey, pharmaceutical and biotech companies cited the short supply of analysts as a particular problem. Typically employed on a contract basis, analysts must be graduate- or PhD-level candidates, so their shortfall suggests that the shortage of qualified British life science researchers could continue.

Science graduates may also lack the specific skills employers seek. SRG believes the gap is widening between what science industries want and what they get in respect of the availability, quantity, and quality of new recruits. While 94% of the employers surveyed expressed satisfaction with disciplines taught in universities, on other measures, companies still report that graduates who pursue science careers lack required skills and knowledge. Thirty-eight percent of employers describe a shortage of graduate talent with up-to-date practical experience. In the fast-moving field of genomics, for example, fresh graduates are unlikely to exhibit state-of-the-art technical skills or much in the way of practical ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies